Page last updated: 2024-08-23

mifepristone and Bone Diseases, Metabolic

mifepristone has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liggitt, D; Nelson, AM; Ware, CB1

Other Studies

1 other study(ies) available for mifepristone and Bone Diseases, Metabolic

ArticleYear
Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.
    Reproductive biology and endocrinology : RB&E, 2003, May-16, Volume: 1

    Topics: Abnormalities, Multiple; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Bone Diseases, Metabolic; Corticosterone; Female; Fetal Diseases; Fetus; Genes, Lethal; Gestational Age; Homeostasis; Hormone Antagonists; Hypothalamo-Hypophyseal System; Interleukin-6; Leukemia Inhibitory Factor; Leukemia Inhibitory Factor Receptor alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Muscle, Skeletal; Neuroglia; Neuroimmunomodulation; Pituitary-Adrenal System; Pregnancy; Proteins; Receptors, Cytokine; Receptors, Glucocorticoid; Receptors, OSM-LIF; Specific Pathogen-Free Organisms; Spinal Cord

2003